PMID- 19531107
OWN - NLM
STAT- MEDLINE
DCOM- 20091013
LR  - 20220318
IS  - 1440-1819 (Electronic)
IS  - 1323-1316 (Linking)
VI  - 63
IP  - 4
DP  - 2009 Aug
TI  - Subjective assessments of the quality of life, well-being and self-efficacy in 
      patients with schizophrenia.
PG  - 521-8
LID - 10.1111/j.1440-1819.2009.01995.x [doi]
AB  - AIM: The present study examined three kinds of subjective assessment scales in 
      the same patient group with schizophrenia to analyze the correlations among 
      scores obtained in relation to the background data. METHOD: Thirty-six patients 
      with schizophrenia were examined with the 26-item short form of the World Health 
      Organization Quality of Life (WHO-QOL 26), Subjective Well-being under 
      Neuroleptic drug treatment: Short Japanese version (SWNS) and Self-Efficacy for 
      Community Life scale (SECL) for subjective assessment scales, five kinds of 
      neurocognitive tests, Positive and Negative Syndrome Scale (PANSS) for clinical 
      symptom, Social Functioning Scale (SFS), and Global Assessment of Functioning 
      (GAF) scale for social functioning. RESULT: The scores for delusions (components 
      of positive syndrome), anxiety and depression (components of general 
      psychopathology) on the PANSS significantly correlated with QoL and subjective 
      well-being scores. In contrast, the scores for components of negative syndrome 
      were not correlated with the subjective assessment scores. Furthermore, none of 
      the clinical symptom scores were correlated with the score in self-efficacy 
      scale. The SFS and GAF scores were significantly correlated with the subjective 
      assessment scores. There were significant correlations among the scores on the 
      three subjective assessment scales. CONCLUSION: Each scale has different features 
      and should be utilized depending upon the expected effect of treatment or the 
      purpose of assessment. The treatments provided to patients must be directed at 
      improving both psychological and social impairments, in order to enhance the 
      social functioning and QoL of patients.
FAU - Chino, Bun
AU  - Chino B
AD  - Department of Neuropsychiatry, Ginza Taimei Clinic, Tokyo, Japan. 
      gi026037@hotmail.com
FAU - Nemoto, Takahiro
AU  - Nemoto T
FAU - Fujii, Chiyo
AU  - Fujii C
FAU - Mizuno, Masafumi
AU  - Mizuno M
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20090615
PL  - Australia
TA  - Psychiatry Clin Neurosci
JT  - Psychiatry and clinical neurosciences
JID - 9513551
RN  - 0 (Antipsychotic Agents)
SB  - IM
MH  - Adult
MH  - Antipsychotic Agents/therapeutic use
MH  - Attitude to Health
MH  - Cognition Disorders/diagnosis
MH  - Female
MH  - *Health Status
MH  - Humans
MH  - Male
MH  - Neuropsychological Tests
MH  - Personal Satisfaction
MH  - Personality Inventory
MH  - Psychiatric Status Rating Scales/*statistics & numerical data
MH  - *Quality of Life/psychology
MH  - Schizophrenia/*diagnosis/drug therapy
MH  - *Schizophrenic Psychology
MH  - *Self Efficacy
MH  - Social Adjustment
MH  - Surveys and Questionnaires
EDAT- 2009/06/18 09:00
MHDA- 2009/10/14 06:00
CRDT- 2009/06/18 09:00
PHST- 2009/06/18 09:00 [entrez]
PHST- 2009/06/18 09:00 [pubmed]
PHST- 2009/10/14 06:00 [medline]
AID - PCN1995 [pii]
AID - 10.1111/j.1440-1819.2009.01995.x [doi]
PST - ppublish
SO  - Psychiatry Clin Neurosci. 2009 Aug;63(4):521-8. doi: 
      10.1111/j.1440-1819.2009.01995.x. Epub 2009 Jun 15.